ABT Abbott Labs

TIDMABT

RNS Number : 6632S

Abbott Laboratories

18 March 2016

Notification to RNS

   Company:         Abbott Laboratories 
   TIDM:              ABT 
   Headline:          Abbott Laboratories Files Proxy Statement 

Abbott Laboratories (the "Company")

18 March 2016

Abbott Laboratories Files Proxy Statement

The Company informs its shareholders that on 18 March 2016, in accordance with the U.S. Securities Exchange Act of 1934, as amended, a definitive proxy statement (the "Proxy Statement") was filed with the U.S. Securities and Exchange Commission ("SEC"). The Proxy Statement can be found on the SEC website at http://www.sec.gov.

A copy of the Proxy Statement has been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.

Issued by: Abbott Laboratories

CONTACT: Financial, Scott Leinenweber, +1-224-668-0791, or Media, Scott Stoffel, +1-224-668-5201.

This information is provided by RNS

The company news service from the London Stock Exchange

END

STRAKFDBDBKBCND

(END) Dow Jones Newswires

March 21, 2016 03:00 ET (07:00 GMT)

Abbott Labs (LSE:ABT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Abbott Labs (LSE:ABT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024